Seoul, South Korea

Hyun Tae Son

USPTO Granted Patents = 5 

Average Co-Inventor Count = 10.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
5 patents (USPTO):

Title: Innovator in Cell Therapy: Hyun Tae Son

Introduction

Hyun Tae Son is a notable inventor based in Seoul, South Korea, recognized for his contributions to the field of biomedical innovations. With a total of four patents to his name, he has made significant strides in the development of cell therapies, particularly in the area of chimeric antigen receptors.

Latest Patents

Among his most recent inventions is a groundbreaking chimeric antigen receptor (CAR) that binds to HLA-DR, offering new possibilities in CAR-T cell therapy. This invention features a unique antigen-binding molecule that comprises a heavy chain variable region with specific amino acid sequences, corresponding to heavy-chain complementarity-determining regions (HCDR1, HCDR2, HCDR3) and a light-chain variable region with complementary light-chain regions (LCDR1, LCDR2, LCDR3). This innovative T cell receptor aims to enhance the efficacy of T cell therapies in combating various diseases.

Another notable patent held by Hyun Tae Son involves anti-human VSIG4 antibodies and their uses. This invention reflects the broad potential applications of such antibodies, laying the foundation for further research and development in therapeutic contexts. The scope of this patent emphasizes its utility while illustrating the dynamic nature of biopharmaceutical innovations.

Career Highlights

Hyun Tae Son is currently associated with Eutilex Co., Ltd., a company that is making a remarkable impact in the field of immunotherapy. His work has not only earned him recognition but also positioned him at the forefront of scientific advancements aimed at improving patient outcomes in cancer treatment.

Collaborations

During his career, he has collaborated with talented colleagues, including Seung Hyun Lee and Sun Woo Im. Together, they have contributed to the innovative research environment at Eutilex Co., Ltd., fostering a culture of creativity and scientific inquiry that is essential for successful breakthroughs in medical technology.

Conclusion

With his innovative patents and collaborative spirit, Hyun Tae Son exemplifies the role of inventors in advancing healthcare technologies. His work on chimeric antigen receptors and related therapeutic modalities highlights the importance of innovation in developing effective treatments for pressing medical challenges. His journey is a testament to the significant impact that dedicated inventors can have on improving lives through science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…